Volker Möbus

Goethe University Frankfurt — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

42h-index5.1kcitations256works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(89), Cancer Treatment and Pharmacology(62), HER2/EGFR in Cancer Research(51), Ovarian cancer diagnosis and treatment(39), Advanced Breast Cancer Therapies(36)

Publications254 total

Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial
The Lancet Regional Health - Europe·2024· 6 citedOpen Access
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
Journal of Clinical Oncology·2024· 9 citedOpen Access
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer
Breast Cancer Research and Treatment·2024· 5 citedOpen Access
111MO Tailored dose-dense versus standard adjuvant chemotherapy for high-risk early breast cancer: Efficacy outcomes and key subgroups after 10 years of follow-up in the randomized phase III PANTHER trial
ESMO Open·2024Open Access
Autoren
Elsevier eBooks·2024Open Access
Clinical Axillary Staging in Breast Cancer Patients Using Ultrasound Imaging
Breast Care·2024· 2 citedOpen Access
Mammakarzinom
Elsevier eBooks·2024
Breast Cancer Outcome: What Have We Achieved
Breast Care·2023· 1 citedOpen Access
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study
The Breast·2022· 5 citedOpen Access
Effects of capecitabine as part of neo-/adjuvant chemotherapy – A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients
European Journal of Cancer·2022· 25 cited
AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021
Senologie - Zeitschrift für Mammadiagnostik und -therapie·2022Open Access
Abstract OT1-02-01: Phase III postneoadjuvant study evaluating sacituzumab govitecan (SG), an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment - SASCIA
Cancer Research·2022
Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial
Cancers·2022· 24 citedOpen Access
<i>mdm2</i> gene amplification is associated with luminal breast cancer progression in humanized <scp>PDX</scp> mice and a worse outcome of estrogen receptor positive disease
International Journal of Cancer·2021· 11 citedOpen Access
Autoreninnen und Autoren
Elsevier eBooks·2021
Mammakarzinom
Elsevier eBooks·2021
Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer
European Journal of Cancer·2021· 31 cited
Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update
Geburtshilfe und Frauenheilkunde·2021· 1 citedOpen Access
AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update
Geburtshilfe und Frauenheilkunde·2021· 24 citedOpen Access
Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer
BMC Cancer·2021Open Access
page 1 of 13Next →

Frequent Co-authors

Michael Untch(22), Sibylle Loibl(20), Christoph Thomssen(20), Christian Jackisch(18), Jens Huober(18), Nadia Harbeck(16), Andreas Schneeweiß(16), Gϋnter von Minckwitz(16), Peter A. Fasching(15), Jens‐Uwe Blohmer(14), R. Kreienberg(14), Tanja Fehm(12), Volkmar Müller(12), Valentina Nekljudova(11), Elmar Stickeler(10), Wolfgang Janni(9), Carsten Denkert(9), Bernd Gerber(8), Hans‐Joachim Lück(8), Hans Tesch(8)